Bone-on-a-chip recapitulates dynamic bone remodeling.

Area of Science:

• Biotechnology
• Regenerative Medicine
• Biomaterials

Background:

• Bone remodeling, governed by the basic multicellular unit (BMU), is vital for skeletal health but poorly understood due to limitations in current analysis models.
• Existing models fail to capture the dynamic, spatiotemporal events occurring within the BMU during bone remodeling, hindering research into bone diseases like osteoporosis.

Purpose of the Study:

• To develop and validate an advanced "bone-on-a-chip" model for dynamic, spatiotemporal analysis of bone remodeling processes.
• To investigate bone regeneration, homeostasis, and osteoporotic conditions using this novel in vitro model.
• To assess the model's utility as a platform for drug testing in bone-related diseases.

Main Methods:

• Development of a microfluidic device enabling dynamic co-culture of osteoblasts (OBs) and osteoclasts (OCs).
• Utilized stem cell technologies for cell differentiation and integration within the chip.
• Employed RNA sequencing to analyze gene expression and compare model characteristics to in vivo conditions.

Main Results:

• The bone-on-a-chip model successfully recapitulated key bone remodeling events, including cell migration, differentiation, and coupling within the BMU.
• RNA sequencing revealed that the model exhibits pronounced osteoporotic features, closely resembling pathological remodeling in osteoporotic mice.
• The model accurately predicted the antiresorptive effects of two anti-osteoporosis drugs, validating its potential for drug screening.

Conclusions:

• The developed microfluidic bone-on-a-chip model provides an unprecedented platform for studying dynamic bone remodeling processes in a spatiotemporal context.
• This model serves as a valuable tool for understanding bone pathophysiology, particularly in osteoporosis.
• The bone-on-a-chip system offers a promising and potentially more accurate alternative to conventional methods for testing anti-osteoporosis drugs.